Literature DB >> 2269245

Calculating excess lifetime risk in relative risk models.

M Vaeth1, D A Pierce.   

Abstract

When assessing the impact of radiation exposure it is common practice to present the final conclusions in terms of excess lifetime cancer risk in a population exposed to a given dose. The present investigation is mainly a methodological study focusing on some of the major issues and uncertainties involved in calculating such excess lifetime risks and related risk projection methods. The age-constant relative risk model used in the recent analyses of the cancer mortality that was observed in the follow-up of the cohort of A-bomb survivors in Hiroshima and Nagasaki is used to describe the effect of the exposure on the cancer mortality. In this type of model the excess relative risk is constant in age-at-risk, but depends on the age-at-exposure. Calculation of excess lifetime risks usually requires rather complicated life-table computations. In this paper we propose a simple approximation to the excess lifetime risk; the validity of the approximation for low levels of exposure is justified empirically as well as theoretically. This approximation provides important guidance in understanding the influence of the various factors involved in risk projections. Among the further topics considered are the influence of a latent period, the additional problems involved in calculations of site-specific excess lifetime cancer risks, the consequences of a leveling off or a plateau in the excess relative risk, and the uncertainties involved in transferring results from one population to another. The main part of this study relates to the situation with a single, instantaneous exposure, but a brief discussion is also given of the problem with a continuous exposure at a low-dose rate.

Entities:  

Mesh:

Year:  1990        PMID: 2269245      PMCID: PMC1567825          DOI: 10.1289/ehp.908783

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  6 in total

1.  Measuring the benefit of reduced exposure to environmental carcinogens.

Authors:  M Gail
Journal:  J Chronic Dis       Date:  1975-03

2.  Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants.

Authors:  H Kato; C C Brown; D G Hoel; W J Schull
Journal:  Radiat Res       Date:  1982-08       Impact factor: 2.841

3.  The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.

Authors:  D L Preston; D A Pierce
Journal:  Radiat Res       Date:  1988-06       Impact factor: 2.841

4.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.

Authors:  Y Shimizu; H Kato; W J Schull; D L Preston; S Fujita; D A Pierce
Journal:  Radiat Res       Date:  1989-06       Impact factor: 2.841

5.  A multistage approach to the cohort analysis of lifetime lung cancer risk among steelworkers exposed to coke oven emissions.

Authors:  M H Dong; C K Redmond; S Mazumdar; J P Costantino
Journal:  Am J Epidemiol       Date:  1988-10       Impact factor: 4.897

6.  Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982.

Authors:  D L Preston; H Kato; K Kopecky; S Fujita
Journal:  Radiat Res       Date:  1987-07       Impact factor: 2.841

  6 in total
  14 in total

1.  Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.

Authors:  Michael K O'Connor; Hua Li; Deborah J Rhodes; Carrie B Hruska; Conor B Clancy; Richard J Vetter
Journal:  Med Phys       Date:  2010-12       Impact factor: 4.071

2.  PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposure.

Authors:  Wolfgang Eschner; Matthias Schmidt; Markus Dietlein; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

3.  Quantifying Cancer Risk from Radiation.

Authors:  Alexander P Keil; David B Richardson
Journal:  Risk Anal       Date:  2017-12-06       Impact factor: 4.000

4.  Predicted cancer risks induced by computed tomography examinations during childhood, by a quantitative risk assessment approach.

Authors:  Neige Journy; Sophie Ancelet; Jean-Luc Rehel; Myriam Mezzarobba; Bernard Aubert; Dominique Laurier; Marie-Odile Bernier
Journal:  Radiat Environ Biophys       Date:  2013-10-09       Impact factor: 1.925

5.  A hybrid likelihood algorithm for risk modelling.

Authors:  A M Kellerer; M Kreisheimer; D Chmelevsky; D Barclay
Journal:  Radiat Environ Biophys       Date:  1995-03       Impact factor: 1.925

6.  A method for determining weights for excess relative risk and excess absolute risk when applied in the calculation of lifetime risk of cancer from radiation exposure.

Authors:  Linda Walsh; Uwe Schneider
Journal:  Radiat Environ Biophys       Date:  2012-11-20       Impact factor: 1.925

7.  A bespoke health risk assessment methodology for the radiation protection of astronauts.

Authors:  Linda Walsh; Luana Hafner; Ulrich Straube; Alexander Ulanowski; Anna Fogtman; Marco Durante; Guillaume Weerts; Uwe Schneider
Journal:  Radiat Environ Biophys       Date:  2021-04-30       Impact factor: 1.925

8.  Lung cancer risk among German male uranium miners: a cohort study, 1946-1998.

Authors:  B Grosche; M Kreuzer; M Kreisheimer; M Schnelzer; A Tschense
Journal:  Br J Cancer       Date:  2006-10-17       Impact factor: 7.640

9.  Assessment of risk for asthma initiation and cancer and heart disease deaths among patrons and servers due to secondhand smoke exposure in restaurants and bars.

Authors:  Ruiling Liu; David L Bohac; Lara A Gundel; Martha J Hewett; Michael G Apte; S Katharine Hammond
Journal:  Tob Control       Date:  2013-02-13       Impact factor: 7.552

10.  Data on assessment excess lifetime cancer risk and risk of lung cancer from inhalation of Radon 222 in radiotherapy centers in Tehran, Iran.

Authors:  Mohammad Mirdoraghi; Safdar Masoumi; Daniel Einor
Journal:  Data Brief       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.